ABVC Biopharma Inc banner

Intrinsic Value

The intrinsic value of ABVC Biopharma Inc (ABVC) under the Base Case is 0.0003 USD per share. Compared with the current market price of 0.8663 USD, the stock appears Overvalued by 100% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

ABVC Intrinsic Value
$0.0003
Overvaluation 100%
Intrinsic Value
Price $0.8663
Alert me when ABVC is below its intrinsic value
Today $0.0002 · 100.0% below the current price

ABVC is more expensive than usual. It was this expensive or more expensive on just 13% of days in the past 5 years.

Alternatives to ABVC

Fundamental Analysis

What ABVC Biopharma Does

Biotechnology Health Care

ABVC Biopharma is a drug-development company that focuses on plant-based medicines. It works on turning natural compounds into prescription drug candidates, with a big emphasis on therapies for brain and nervous system conditions, cancer-related uses, and eye diseases. The company is not a mass-market drug seller; it is mainly a development-stage biotech that builds candidates, tests them, and tries to advance them through the regulatory process.

Headquarters
United States of America US
Employees
19
IPO date
Nov 9, 2004
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue ABVC Research

Decided on ABVC Biopharma? Get an email when ABVC reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one ABVC stock?

The intrinsic value for ABVC Biopharma Inc (ABVC) under the Base Case is 0.0003 USD.

Is ABVC stock undervalued or overvalued?

Compared with the current market price of 0.8663 USD, the stock appears Overvalued by 100% .

How reliable are our estimates? See how past valuations played out
Back to Top